Kala Pharmaceuticals Inc (KALA) stock is down -38.49% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives KALA stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 1. KALA's rank also includes a long-term technical score of 4. The fundamental score for KALA is 96. In addition to the average rating from Wall Street analysts, KALA stock has a mean target price of 20.714. This means analysts expect the stock to increase 217.70% over the next 12 months.
What's Happening with KALA Stock Today
Kala Pharmaceuticals Inc (KALA) stock has fallen -6.46% while the S&P 500 is down -1.11% as of 10:46 AM on Tuesday, May 4. KALA is down -$0.45 from the previous closing price of $6.97 on volume of 1,245,277 shares. Over the past year the S&P 500 is higher by 45.85% while KALA is down -38.49%. KALA lost -$1.99 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Kala Pharmaceuticals Inc (KALA) Stock.